Amyris

Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to the health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Earnings data Q1 2024

The principal business of Tara Gold Resources Corp. is the acquisition, exploration and development of high-quality precious metals projects with potential for economic commercial value. Tara Gold is currently focused on acquiring and developing properties in the natural resource belt of the Sierra Madre Occidental and other prolific areas in the states of Chihuahua, Sonora, and Sinaloa, Mexico.  Tara Gold provides investors growth exposure with a diversified exploration portfolio, multiple multi-million ounce targets and several near term production scenarios. Tara Gold owns equity positions in Cayden Resources Inc. (TSX-V: CYD) and Tara Minerals Corp. (TARM.OB), a public US company which explores and develops high-quality precious & non-precious metals and mineral projects in Mexico.

Amyris' disruptive vertically-integrated business model should deliver favorable results beginning in H2 2022, linking synthetic biology, clean chemistry, precision fermentation, scaling, & hero ingredients with consumers, partners, & retailers. After spending $2+ billion over 15+ years developing revolutionary science, Q3 startups of a next-generation fermentation facility and finishing plants should significantly boost Amyris profitability for Ingredients and Consumer Products.

Amyris' Vertically-Integrated Business Model Transitioning From Investment Mode To Payoff Mode

EMERYVILLE, Calif. , Aug. 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management will participate in a fireside chat at the UBS Genomics 2.0 and MedTech Innovations Summit on Wednesday, August 10, 2022, at 3:00 pm PT/ 6:00 pm ET in Dana Point, CA.

AMYRIS TO PARTICIPATE AT THE UBS GENOMICS 2.0 AND MEDTECH INNOVATIONS SUMMIT

EMERYVILLE, Calif. , July 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it will issue its financial results for the second quarter ended June 30, 2022, on the morning of Tuesday, August 9, 2022, prior to the opening of the financial markets.

AMYRIS TO HOST SECOND QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 9

There are high hopes that Amyris' Barra Bonita plant will rein in costs and improve the company's profitability. Fermentation is just one cost component though, meaning Barra Bonita will only have a limited impact, particularly on the consumer business.

Amyris: Revenues Need To Catch Expenses

Arcimoto

Pennsylvania Real Estate Investment Trust

Short squeeze penny stocks to watch. The post 3 Short Squeeze Penny Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Short Squeeze Penny Stocks To Watch Before Next Week

Adobe

Cognex

This basket of infrastructure software, technical instrument, and specialty chemicals stocks looks like a good value.

3 Tech Stocks at the Top of Our Watchlists

EMERYVILLE, Calif. , June 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it has successfully started fermentation at its new precision fermentation plant in Barra Bonita, Brazil.

AMYRIS BARRA BONITA FERMENTATION PLANT BEGINS INDUSTRIAL PRODUCTION

EMERYVILLE, Calif. , June 7, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management will participate in a virtual fireside chat at the Oppenheimer 22nd Annual Consumer Conference on Tuesday, June 14, 2022, at 11:15 am ET.

AMYRIS TO PARTICIPATE AT THE OPPENHEIMER 22nd ANNUAL CONSUMER CONFERENCE

Lovesac Company

Invitae

Find out why the pros think these stocks could gain 200% or better.

3 Stocks Wall Street Thinks Could Triple Your Money or Better

EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that management is participating in fireside chats at the following investor conferences this week: Morgan Stanley Sustainable Futures Conference, Monday, May 23 at 2:00 PM ET (virtual) Cowen 6th Annual Future of the Consumer Conference, Tuesday, May 24 at 10:40 AM ET (in-person) UBS Global Healthcare Conference, Wednesday, May 25 at 11:30 AM ET (in-person) Live webcasts of the presentations and replays will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.

AMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022

EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform, today announced that management will participate in fireside chats at the following upcoming investor conferences.

AMYRIS TO PARTICIPATE AT MAY INVESTOR CONFERENCES

Ginkgo Bioworks Holdings

Which of these fallen stocks has the best chance of recovery?

Better Buy: Gingko Bioworks vs. Amyris

Amyris' cash burn is currently high and their balance sheet weak, placing them in a vulnerable position as sentiment deteriorates. The business continues to expand rapidly, but margin improvements have stalled as investments have increased and supply constraints have elevated costs.

Amyris: A Question Of Agency Costs

Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.

Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1

Discussing sell-off in the shares after the company's Q1 report revealed a much higher cash usage than anticipated by market participants. Even when assuming cash usage to trend down for the remainder of the year, Amyris would likely run out of funds by the end of Q4 at the latest.

Amyris: Elevated Cash Usage Causes Investors To Head For The Exits

Amyris, Inc. (NASDAQ:AMRS ) Q1 2022 Results Conference Call May 10, 2022 9:00 AM ET Company Participants John Melo - President and Chief Executive Officer Han Kieftenbeld - Chief Financial Officer Conference Call Participants Colin Rusch - Oppenheimer Steven Mah - Cowen Sameer Joshi - H.C. Wainwright Laurence Alexander - Jefferies Michael Freeman - Raymond James Rachel Vatnsdal - JP Morgan Graham Tanaka - Tanaka Capital Management Operator Welcome to the Amyris' First Quarter 2022 Financial Results Conference Call.

Amyris, Inc. (AMRS) CEO John Melo on Q1 2022 Results - Earnings Call Transcript

Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -54.17% and 11.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Amyris, Inc. (AMRS) Reports Q1 Loss, Misses Revenue Estimates

Record consumer revenue of $34.6 million increased 121% compared to Q1 2021 Barra Bonita commissioning on track to commence ingredients production in Q2 EMERYVILLE, Calif. , May 10, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM technology platform, today announced financial results for the first quarter ended March 31, 2022.

AMYRIS, INC. REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS

EMERYVILLE, Calif. , May 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it will issue its financial results for the first quarter ended March 31, 2022, on the morning of Tuesday, May 10, 2022, prior to the opening of the financial markets.

AMYRIS TO HOST FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON MAY 10

2022 is the year of the “Brick” for Amyris as it completes construction of the World's Largest Fermentation Plant, Consumer Production Facilities, and entry into global “Brick-and-Mortar” Retail Chain Stores. Amyris continues to achieve scale across Geographies, Retail Partners, Brands, and Product Lines.

Amryis Update: Building Value One Brick At A Time

EMERYVILLE, Calif. , April 14, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, successfully hosted an in-person investor event following the Company's Nasdaq Opening Bell Ringing Ceremony.

AMYRIS HOSTS SUCCESSFUL INVESTOR EVENT

EMERYVILLE, Calif. , April 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that it has started the commissioning of its new fermentation plant in Barra Bonita, Brazil.

AMYRIS STARTS COMMISSIONING OF INDUSTRY LEADING FERMENTATION PLANT

Clear Channel Outdoor Holdings

Globalstar

Which penny stocks are you watching in April? The post Will These Penny Stocks Explode in April?

Will These Penny Stocks Explode in April? 3 to Watch This Week

JVN Hair is a haircare brand that Amyris launched in 2021. The products are based around hemisqualane and the brand is fronted by Jonathan Van Ness.

Amyris: JVN Could Be Their Most Valuable Brand Yet

EMERYVILLE, Calif. , March 17, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that management will participate in a fireside chat at the Jefferies Virtual Synthetic Biology Week on Wednesday, March 23, 2022, at 2:00 pm ET.

News for Amyris Stock (AMRS)